{"filing":{"accession_number":"0001193125-26-245636","cik":"0001856725","ticker":"RANI","company_name":"Rani Therapeutics Holdings, Inc.","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"rani-20260528.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1856725/000119312526245636/rani-20260528.htm"},"events":[{"id":8081,"run_id":7095,"accession_number":"0001193125-26-245636","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Rani Therapeutics' annual meeting held on May 28, 2026. The filing reports voting outcomes for two proposals: (1) election of seven director nominees, with vote tallies for each candidate (For/Withheld/Broker Non-Votes), and (2) ratification of CBIZ CPAs P.C. as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the composition of the board and auditor selection.","company_name":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2656,"accession_number":"0001193125-26-245636","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Rani Therapeutics' annual meeting held on May 28, 2026. The filing reports voting outcomes for two proposals: (1) election of seven director nominees, with vote tallies for each candidate (For/Withheld/Broker Non-Votes), and (2) ratification of CBIZ CPAs P.C. as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the composition of the board and auditor selection.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:09:44.979369+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2656,"accession_number":"0001193125-26-245636","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Rani Therapeutics' annual meeting held on May 28, 2026. The filing reports voting outcomes for two proposals: (1) election of seven director nominees, with vote tallies for each candidate (For/Withheld/Broker Non-Votes), and (2) ratification of CBIZ CPAs P.C. as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the composition of the board and auditor selection.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:09:44.979369+00:00","company_name":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","filing_date":"2026-05-29"}]}